课题基金 / 基金详情

项目摘要

项目成果

GOKUL M. DAS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Mechanism of gene transcription and its regulation will be studied in polyoma virus (PV). The regulatory region of the virus is located between the coding sequences of two sets of genes transcribed divergently from presumably overlapping promoters early and late in infection. The primary objectives of the proposed project are to define the elements of individual promoter and to understand the regulation of transcription of these genes. The latter involves specific sets of DNA-protein and protein-protein interactions among promoter DNA sequences, cellular RNA polymerase IL, cellular transcription factors and the viral regulatory protein T antigen. The objectives will be achieved by introducing mutations systematically in the promoter region by in vitro procedures and by testing the promoter activity in vivo and, in vitro in Hela Cell extracts. For in vivo assay, the promoter will be linked to the chloramphenicol acetyltransferase (CATase) gene of E. coli to make the CATase in the mammalian cell where it is normally absent. The amount of the enzyme synthesized will be taken as a measure of the promoter activity. Different cell lines, such as mouse (3T6), undifferentiated embryonal carcinoma (PCC4, F9) and differentiated cells (Friend erythroleukemic cell) will be used for in vivo characterization of the mutants. The "optimal" PV enhancer structure selected as the one best responding to the cellular factor(s) in these cell lines will be defined. The mechanism of regulation of the early transcription and that of the activation of late transcription by T antigen will be studied in vivo and in vitro. Two possible models that will be tested for the switch-over mechanism from "early- early" to the "late-early" or from the "early" to "late" transcription are a) whether this shift is a direct effect of T antigen binding to the regulatory region b) whether T antigen plays an indirect role because of its role in DNA replication. The cellular factor(s) involved in transcription will be identified by competition transcriptional and DNA binding assay and their points of contact on the template, will be determined by DNase protection experiments in vitro and in vivo, in absence or presence of T antigen. Experiments parallel to those conducted in vitro with naked DNA as template will be carried out with PV minichromosome reconstituted in vitro or isolated from infected cells or from mature virions. The possibility of sequence-directed or protein-induced bending of the regulatory region will be tested.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
The A enhancer of polyomavirus: protein-protein interactions for the differential early and late promoter function under nonreplicating conditions.
多瘤病毒的 A 增强子:非复制条件下早期和晚期启动子功能差异的蛋白质-蛋白质相互作用。
DOI: 10.1159/000024921
发表时间: 1998
期刊: Intervirology
影响因子: 4.6
作者: [Shivakumar,CV, Das,GC]
通讯作者: Das,GC
Cell-specific modulation of the papovavirus promoters by tumor-suppressor protein p53 in the absence of large T-antigen.
在大 T 抗原不存在的情况下,肿瘤抑制蛋白 p53 对乳多空病毒启动子的细胞特异性调节。
DOI: --
发表时间: 1995
期刊: Oncogene.
影响因子: --
作者: [Das,GC, Shivakumar,CV, Todd,SD]
通讯作者: Todd,SD
Biochemical and mutational analysis of the polyomavirus core promoter: involvement of nuclear factor-1 in early promoter function.
多瘤病毒核心启动子的生化和突变分析:核因子 1 参与早期启动子功能。
DOI: 10.1099/0022-1317-75-6-1281
发表时间: 1994
期刊: The Journal of general virology
影响因子: --
作者: [Shivakumar,CV, Das,GC]
通讯作者: Das,GC
Identification of proteins binding to the F441 locus of polyomavirus B enhancer that are required for its activity in embryonic carcinoma cells.
鉴定与多瘤病毒 B 增强子 F441 位点结合的蛋白质,这是其在胚胎癌细胞中发挥活性所必需的。
DOI: 10.1099/0022-1317-74-4-597
发表时间: 1993
期刊: The Journal of general virology
影响因子: --
作者: [DasGupta,S, Shivakumar,CV, Das,GC]
通讯作者: Das,GC
Functional Significance of individual p53 mutations in determining the role of estrogen receptor beta in triple negative breast cancer
Functional Significance of individual p53 mutations in determining the role of estrogen receptor beta in triple negative breast cancer
Functional Significance of individual p53 mutations in determining the role of estrogen receptor beta in triple negative breast cancer
Therapeutic implication of estrogen receptor-p53 interaction in mitochondria
海外基金